Key findings from the Consortium also included a presentation titled “Online workflow for the First-in-Man study on bone metastases at the MRI-linear accelerator” (Abstract OC-0163), which was delivered by Lieke Meijers, Radiotherapy Technologist at UMC Utrecht. The study discussed in this presentation was designed to test the feasibility of an online workflow for patients with bone metastases to be treated on the Elekta Unity system. Using a body-shaped testing device containing material equivalent to human tissues (Alderson Phantom), researchers determined that the developed protocol allowed for a total workflow time of about 45 minutes. This work flow includes patient set-up imaging, registration contouring, treatment planning, position verification, dose delivery and post-irradiation position verification scan.
“MR/RT is an area of great excitement within the radiation oncology community and the data presented at ESTRO 36 highlight the potential for Elekta Unity to transform the way cancer patients are treated,” said Kevin Brown, Vice President Research and Innovation at Elekta. “Researchers conceptualized MR-linac nearly two decades ago, and the Consortium members have demonstrated a tireless commitment to realizing the breakthroughs that made Unity possible. The twenty abstracts presented at this prestigious conference reflect their vision and commitment to ensuring that all patients who may benefit from radiation therapy achieve optimal outcomes.”
For more information, please visit www.elekta.com/Unity.
Elekta Unity is a work in progress and not available for sale or distribution. (REGMAR)
About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.
Back to HCB News
